June 16, 2024

Approval granted to use Coronil as a supportive measure in the management of Covid: MoS Health

25 July 2021 | TITN Team
Share

According to Lok Sabha on Friday, the National Licensing Authority of Uttarakhand has approved the use of coronil pills as a supportive measure for the treatment of Covid19 without the need for treatment based on the recommendations of the review committee established by the AYUSH Ministry.

The Minister of Health Bharati Pravin Pavar stated in a written response that the Interdisciplinary Technical Review Committee (ITRC) established by the AYUSH Ministry has reviewed the application of the Patanjali Research Foundation to “renew the AYUSH license for Divya Coronil tablets” and “pass” the immunization The booster “to “COVID19 drugs”.

The report stated that the committee has proposed the use of tablets as a support measure in response to Covid.

“The application titled ‘Updating AYUSH license for Divya Coronil tablet from Immunity booster to Medicine for Covid-19’ submitted by Patanjali Research Foundation Trust, Haridwar, Uttarakhand to this Ministry, was placed before the ITRC on October 27, 2020 for examination of the applications/claims on patent and propriety (P&P) ASU&H medicines with new indications or repurposing of licensed P&P, ASU&H medicines for Covid-19,” Pawar said in her reply.